1. Home
  2. IDYA vs UNFI Comparison

IDYA vs UNFI Comparison

Compare IDYA & UNFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • UNFI
  • Stock Information
  • Founded
  • IDYA 2015
  • UNFI 1976
  • Country
  • IDYA United States
  • UNFI United States
  • Employees
  • IDYA N/A
  • UNFI N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • UNFI Food Distributors
  • Sector
  • IDYA Health Care
  • UNFI Consumer Discretionary
  • Exchange
  • IDYA Nasdaq
  • UNFI Nasdaq
  • Market Cap
  • IDYA 1.9B
  • UNFI 1.6B
  • IPO Year
  • IDYA 2019
  • UNFI 1996
  • Fundamental
  • Price
  • IDYA $21.23
  • UNFI $23.21
  • Analyst Decision
  • IDYA Strong Buy
  • UNFI Hold
  • Analyst Count
  • IDYA 13
  • UNFI 8
  • Target Price
  • IDYA $53.42
  • UNFI $26.43
  • AVG Volume (30 Days)
  • IDYA 1.1M
  • UNFI 1.6M
  • Earning Date
  • IDYA 08-05-2025
  • UNFI 06-10-2025
  • Dividend Yield
  • IDYA N/A
  • UNFI N/A
  • EPS Growth
  • IDYA N/A
  • UNFI N/A
  • EPS
  • IDYA N/A
  • UNFI N/A
  • Revenue
  • IDYA $7,000,000.00
  • UNFI $32,243,000,000.00
  • Revenue This Year
  • IDYA $101.20
  • UNFI $4.32
  • Revenue Next Year
  • IDYA $286.70
  • UNFI $0.39
  • P/E Ratio
  • IDYA N/A
  • UNFI N/A
  • Revenue Growth
  • IDYA N/A
  • UNFI 6.62
  • 52 Week Low
  • IDYA $13.45
  • UNFI $11.88
  • 52 Week High
  • IDYA $44.42
  • UNFI $34.76
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 62.23
  • UNFI 41.17
  • Support Level
  • IDYA $21.08
  • UNFI $21.28
  • Resistance Level
  • IDYA $22.37
  • UNFI $22.51
  • Average True Range (ATR)
  • IDYA 0.92
  • UNFI 1.26
  • MACD
  • IDYA -0.09
  • UNFI -0.07
  • Stochastic Oscillator
  • IDYA 61.72
  • UNFI 29.42

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About UNFI United Natural Foods Inc.

United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.

Share on Social Networks: